Vascular Biogenics IPO Undone After Investor Fails To Buy

By Kaitlyn Kiernan ( August 12, 2014, 11:57 AM EDT) -- Vascular Biogenics Ltd. shares made a public debut on the last day of July, trading for six uneventful days before the initial public offering's underwriters made the rare move of saying that trading and the initial public offering actually never happened. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login